Chemo-radiotherapy for advanced non-small cell lung cancer: concurrent or sequential? It's no longer the question: a systematic review-Reference-Cited by-同舟云学术

Chemo-radiotherapy for advanced non-small cell lung cancer: concurrent or sequential? It's no longer the question: a systematic review

Published:2010-01-27 Issue:3 Volume:127 Page:718-728
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Liang Hui-Ying,Zhou Hao,Li Xue-Lian,Yin Zhi-Hua,Guan Peng,Zhou Bao-Sen

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference55 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer;American Society of Clinical Oncology;J Clin Oncol,1997

3. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

4. Radiotherapy and surgery in the management of non-small cell lung cancer in the elderly patients, a review of the recent literature;Ulutin;Cancer Therapy,2005

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrasensitive Response Explains the Benefit of Combination Chemotherapy Despite Drug Antagonism;Molecular Cancer Therapeutics;2024-03-25

2. Predictors of Early Hospice or Death in Patients With Inoperable Lung Cancer Treated With Curative Intent;Clinical Lung Cancer;2023-12

3. A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer;Cancers;2023-03-05

4. Ultrasensitive response explains the benefit of combination chemotherapy despite drug antagonism;2023-02-27

5. Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial;Journal of Thoracic Oncology;2022-12